AGONIST ACTIVITY OF 2-SUBSTITUTED AND 5'-SUBSTITUTED ADENOSINE-ANALOGS AND THEIR N6-CYCLOALKYL DERIVATIVES AT ADENOSINE-A1 AND ADENOSINE-A2 RECEPTORS COUPLED TO ADENYLATE-CYCLASE

被引:47
作者
DALY, JW
PADGETT, WL
机构
[1] Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
关键词
D O I
10.1016/0006-2952(92)90616-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The activity of N6-cycloalkyl derivatives of adenosine, 2-chioroadenosine, 5'-chloroadenosine and N-ethylcarboximidoadenosine (NECA) and of 2-fluoroadenosine and 5-methylthioadenosines were compared at the A1-adenosine receptor inhibitory to adenylate cyclase in rat fat cell membranes and at the A2A-adenosine receptors stimulatory to adenylate cyclase in rat PC12 cell membranes. The N6-cycloalkyl derivatives in all cases were more potent (4- to 23-fold) than the parent compound at the A1 receptor, and were less potent (1.6- to 11-fold) than the parent compound at the A2A receptor. N6-Cyclopentyl-5'-chloroadenosine was the most selective agonist (900-fold) for the A1 receptor, while 2-fluoroadenosine was the only agonist with some selectivity (4.8-fold) for the A2A receptor. 5'-Methylthioadenosine was a weak agonist at both adenosine receptors. A 2-fluoro derivative of 5'methylthioadenosine was somewhat more potent, Affinities of these analogs for inhibition of binding of radioligands to rat brain A1 and A2A receptors are presented.
引用
收藏
页码:1089 / 1093
页数:5
相关论文
共 31 条
[1]   5'-METHYLTHIOADENOSINE AND 2',5'-DIDEOXYADENOSINE BLOCKADE OF THE INHIBITORY EFFECTS OF ADENOSINE ON ADP-INDUCED PLATELET-AGGREGATION BY DIFFERENT MECHANISMS [J].
AGARWAL, KC ;
PARKS, RE .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (18) :2529-2532
[2]  
BRACKETT LE, 1991, J PHARMACOL EXP THER, V257, P205
[3]  
BRISTOL JA, 1988, ADENOSINE ADENINE NU, P17
[4]  
BRUNS RF, 1980, CAN J PHYSIOL PHARM, V58, P673, DOI 10.1139/y80-110
[5]   ADENOSINE RECEPTORS IN BRAIN MEMBRANES - BINDING OF N6-CYCLOHEXYL[H-3]ADENOSINE AND 1,3-DIETHYL-8-[H-3]PHENYLXANTHINE [J].
BRUNS, RF ;
DALY, JW ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5547-5551
[6]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]  
DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
[9]   ADENOSINE RECEPTORS - TARGETS FOR FUTURE DRUGS [J].
DALY, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) :197-207
[10]   HOW DOES ADENOSINE INHIBIT TRANSMITTER RELEASE [J].
FREDHOLM, BB ;
DUNWIDDIE, TV .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (04) :130-134